Citi and others are bullish on biotech, medtech and more
2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. …
2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. …
Piper Sandler named three biotech stocks as its “top picks” for 2024 — citing attractive valuations and pipeline of product launches. The biotech sector has underperformed the S & P …